References
- Aasvee K, Kurvinen E, Jordania R, Jauhiainen M, Sundvall J. Lipoprotein parameters in relation to other risk factors of atherosclerosis in adults and newborns: Tallinn Young Family Study. Scand J Clin Lab Invest 2004;64:245–54.
- Ose L, Iden A, Bakke T, Aarskog D. Neonatal screening for hyperlipidaemia. Postgrad Med J 1975;51:88–92.
- Durant RH, Linder CW, Harkess JW, Gray RG. The relationship between physical activity and serum lipids and lipoproteins in black children and adolescents. J Adolesc Health Care 1983;4:55–60.
- Connor SL, Connor WE, Sexton G, Calvin L, Bacon S. The effects of age, body weight and family relationships on plasma lipoproteins and lipids in men, women and children of randomly selected families. Circulation 1982;65:1290–8.
- Berenson GS, Srinivasan SR, Frank GC, Webber LS. Serum lipid and lipoprotein in infants and children and their relationship with diet. Prog Clin Biol Res 1981;61:73–94.
- Srinivasan SR, Dahlen GH, Jarpa RA, Webber LS, Berenson GS. Racial (black—white) differences in serum lipoprotein(a) distribution and its relation to parental myocardial infarction in children. Bogalusa Heart Study. Circulation 1991;84:160–7.
- Rifai N, Heiss G, Doetsch K. Lipoprotein(a) at birth, in blacks and whites. Atherosclerosis. 92,123–9.
- Loughrey CM, Rimm E, Heiss G, Rifai N. Race and gender differences in cord blood lipoproteins. Atherosclerosis 2000;148:57–65.
- Endo A, Tanzawa K, Kuroda M. Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B, fungal metabolites, having hypocholesterolemic activity. FEBS Lett 1976;72: 323–6.